Why the study?
Paroxysmal AF does not always progress to persistent AF, but the prognostic implications of spontaneous conversion to sinus rhythm in these patients had not been evaluated.
Does spontaneous conversion to sinus rhythm reduce the need for rhythm-control strategies and AF progression in patients with symptomatic paroxysmal atrial fibrillation?
Does spontaneous conversion to sinus rhythm reduce the need for rhythm-control strategies and AF progression in patients with symptomatic paroxysmal atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Spontaneous conversion to sinus rhythm in patients with paroxysmal AF is associated with a lower arrhythmic burden and reduced need for rhythm-control strategies compared to active cardioversion.
Background Paroxysmal atrial fibrillation (PAF) patients do not invariably progress to persistent AF, with a consistent group of patients showing AF regression during follow-up. The prognostic implications of spontaneous conversion (SCV) to sinus rhythm (SR) in those patients has never been evaluated yet. Objective To evaluate the long-term prognostic impact of early SCV to SR in patients presenting with symptomatic, hemo- dynamically stable, PAF in the emergency department (ED). Methods Consecutive patients with symptomatic, hemodynamically stable PAF were included. Patients discharged in SR and followed-up thereafter were stratified based on the occurrence of SCV within 6 h from ED admission. Propensity score matching (PSM) was employed to adjust for relevant baseline differences. The primary outcome was a composite of progression to permanent AF, progression to persistent AF, initiation of antiarrhythmic drugs, AF ablation and need for pharmacologic or electrical cardioversion. Secondary outcomes included AF episodes frequency and individual components of the composite outcome. Results Out of 158 patients, 52 experienced SCV while 106 required active cardioversion. After PSM, 52 matched pairs were analyzed. During a median follow-up of 17.0 months (IQR: 12.8–21.3 months), the primary composite outcome occurred significantly less frequently in the SCV group compared to the non-SCV group (21 vs. 41 events; log-rank p < 0.001). SCV was associated with a significant reduction of primary outcome occurrence (OR 0.361 [95% CI: 0.176; 0.739], p-value 0.005). The SCV group also exhibited a lower arrhythmic burden, with fewer AF episodes (median 1 [3] vs. 2 [4], p < 0.001) and reduced need for cardioversion (p = 0.008). The primary and secondary outcomes did not differ among SCV and non-SCV groups in the unmatched population. Conclusions SCV in patients with PAF is associated with lower arrhythmic burden and reduced need for rhythm-control strategies at follow-up.
No takes yet. Share an insight, caveat, or question.
Cipollone et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: